XCR Diagnostics Inc:企業の製品パイプライン分析

◆英語タイトル:XCR Diagnostics Inc - Product Pipeline Analysis, 2020 Update
◆商品コード:GDME130178PD
◆発行会社(調査会社):GlobalData
◆発行日:2021年1月
◆ページ数:36
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:Medical Devices
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD1,500 ⇒換算¥171,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD2,250 ⇒換算¥256,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
XCR Diagnostics Inc (XCR Diagnostics) is a designer and developer of real-time PCR assays. The company’s products include brucella abortus detection assay, brucella ovis detection assay and custom real time PCR master mix. It offers services such as assay design services, assay design and confirmation services, assay consulting, custom chemical formulation, custom research and development and assay validation, radiance genotyping, and reorder and quality assurance services. XCR Diagnostics also provides sequences of primers, sequences of the fluorescent probes, oligonucleotide sequences, oligonucleotide alignment and amplification protocol. The company serves universities, clinical laboratories, and pharmaceutical companies globally. XCR Diagnostics is headquartered in Salt Lake City, Utah, the US.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company XCR Diagnostics Inc
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
List of Tables
List of Figures
XCR Diagnostics Inc Company Overview
XCR Diagnostics Inc Company Snapshot
XCR Diagnostics Inc Pipeline Products and Ongoing Clinical Trials Overview
XCR Diagnostics Inc – Pipeline Analysis Overview
XCR Diagnostics Inc – Key Facts
XCR Diagnostics Inc – Major Products and Services
XCR Diagnostics Inc Pipeline Products by Development Stage
XCR Diagnostics Inc Pipeline Products Overview
COVID-19 Test
COVID-19 Test Product Overview
Pyramid Portable Nucleic Acid Testing System
Pyramid Portable Nucleic Acid Testing System Product Overview
Pyramid System – BP/BPP Assay
Pyramid System – BP/BPP Assay Product Overview
Pyramid System – C. Difficile Assay
Pyramid System – C. Difficile Assay Product Overview
Pyramid System – Enterovirus/Paraechovirus Assay
Pyramid System – Enterovirus/Paraechovirus Assay Product Overview
Pyramid System – Group A Strep Assay
Pyramid System – Group A Strep Assay Product Overview
Pyramid System – Group B Strep Assay
Pyramid System – Group B Strep Assay Product Overview
Pyramid System – HSV-1/HSV-2/VZV Assay
Pyramid System – HSV-1/HSV-2/VZV Assay Product Overview
Pyramid System – Influenza A/B And RSV Assay
Pyramid System – Influenza A/B And RSV Assay Product Overview
Pyramid System – MRSA Assay
Pyramid System – MRSA Assay Product Overview
Pyramid System – Norovirus Assay
Pyramid System – Norovirus Assay Product Overview
XCR Assay – Group C Streptococcus
XCR Assay – Group C Streptococcus Product Overview
XCR Assay – Group G Streptococcus
XCR Assay – Group G Streptococcus Product Overview
XCR Diagnostics Inc – Key Competitors
XCR Diagnostics Inc – Key Employees
XCR Diagnostics Inc – Locations And Subsidiaries
Head Office
Recent Developments
XCR Diagnostics Inc, Recent Developments
Mar 05, 2020: XCR Diagnostics secures patent for identifying infectious diseases 5X faster than the standard industry test
Dec 18, 2019: XCR Diagnostics announces the appointment of J. Chuck Morrison to its board of directors
Oct 18, 2018: XCR Diagnostics names Daniel Kolk as Vice President of Clinical Development
Aug 10, 2016: Fluoresentric Names Lynda A. Merrill CEO
Apr 13, 2016: XCR Diagnostics Board Appoints Mark Powelson CEO
Oct 14, 2015: Fluoresentric Transfers XCR Portable Diagnostic System IP to XCR Dx Subsidiary
May 13, 2015: Fluoresentric to Launch XCR Dx Subsidiary
Nov 04, 2010: Fluoresentric Releases Advanced Direct-2-PCR Sample Kits For Nasal, Throat, And Cheek Swab Diagnostic Health Tests
Appendix
Methodology
About GlobalData
Contact Us
Disclaimer

List of Tables
XCR Diagnostics Inc Pipeline Products and Ongoing Clinical Trials Overview
XCR Diagnostics Inc Pipeline Products by Equipment Type
XCR Diagnostics Inc Pipeline Products by Indication
XCR Diagnostics Inc, Key Facts
XCR Diagnostics Inc, Major Products and Services
XCR Diagnostics Inc Number of Pipeline Products by Development Stage
XCR Diagnostics Inc Pipeline Products Summary by Development Stage
COVID-19 Test - Product Status
COVID-19 Test - Product Description
Pyramid Portable Nucleic Acid Testing System - Product Status
Pyramid Portable Nucleic Acid Testing System - Product Description
Pyramid System - BP/BPP Assay - Product Status
Pyramid System - BP/BPP Assay - Product Description
Pyramid System - C. Difficile Assay - Product Status
Pyramid System - C. Difficile Assay - Product Description
Pyramid System - Enterovirus/Paraechovirus Assay - Product Status
Pyramid System - Enterovirus/Paraechovirus Assay - Product Description
Pyramid System - Group A Strep Assay - Product Status
Pyramid System - Group A Strep Assay - Product Description
Pyramid System - Group B Strep Assay - Product Status
Pyramid System - Group B Strep Assay - Product Description
Pyramid System - HSV-1/HSV-2/VZV Assay - Product Status
Pyramid System - HSV-1/HSV-2/VZV Assay - Product Description
Pyramid System - Influenza A/B And RSV Assay - Product Status
Pyramid System - Influenza A/B And RSV Assay - Product Description
Pyramid System - MRSA Assay - Product Status
Pyramid System - MRSA Assay - Product Description
Pyramid System - Norovirus Assay - Product Status
Pyramid System - Norovirus Assay - Product Description
XCR Assay - Group C Streptococcus - Product Status
XCR Assay - Group C Streptococcus - Product Description
XCR Assay - Group G Streptococcus - Product Status
XCR Assay - Group G Streptococcus - Product Description
XCR Diagnostics Inc, Key Employees
Glossary

★海外企業調査レポート[XCR Diagnostics Inc:企業の製品パイプライン分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Charter Communications Inc (CHTR):企業の財務・戦略的SWOT分析
    Charter Communications Inc (CHTR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • Oracle Energy Corp (OEC):石油・ガス:M&Aディール及び事業提携情報
    Summary Oracle Energy Corp (Oracle Energy) is an oil and gas company that operates development and redevelopment oil and natural gas projects. The company offers critical assessment and mitigation of risk in oil and gas exploration. It owns and operates oil and gas projects in Portugal's southern Lu …
  • The Arab Assurers Insurance Co.:企業の戦略・SWOT・財務情報
    The Arab Assurers Insurance Co. - Strategy, SWOT and Corporate Finance Report Summary The Arab Assurers Insurance Co. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • Merck & Co Inc (MRK):企業の財務・戦略的SWOT分析
    Merck & Co Inc (MRK) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Daikin Industries Ltd (6367):企業の財務・戦略的SWOT分析
    Daikin Industries Ltd (6367) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Xellia Pharmaceuticals ApS-製薬・医療分野:企業M&A・提携分析
    Summary Xellia Pharmaceuticals ApS (Xellia), a subsidiary of Novo A/S is a healthcare products provider that offers fermented and semi-synthetic APIs and injectable finished dosage forms. The company offers strain and fermentation development with bacteria and fungi. It provides injectable products …
  • Evoqua Water Technologies Corp (AQUA):企業の財務・戦略的SWOT分析
    Evoqua Water Technologies Corp (AQUA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths an …
  • ORBIT Communication Systems Ltd:企業の戦略・SWOT・財務情報
    ORBIT Communication Systems Ltd - Strategy, SWOT and Corporate Finance Report Summary ORBIT Communication Systems Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • Enbridge Inc.:企業の戦略・SWOT・財務情報
    Enbridge Inc. - Strategy, SWOT and Corporate Finance Report Summary Enbridge Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Proofpoint Inc (PFPT):企業の財務・戦略的SWOT分析
    Proofpoint Inc (PFPT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Cogentix Medical Inc (CGNT):医療機器:M&Aディール及び事業提携情報
    Summary Cogentix Medical Inc (Cogentix Medical), formerly Vision-Sciences Inc is a medical device company that offers patient care products. The company offers products such as macroplastique, PrimeSight, urgent pc and ptq products, among others. Its products are used in critical care, faecal incont …
  • Medicenna Therapeutics Corp (MDNA):製薬・医療:M&Aディール及び事業提携情報
    Summary Medicenna Therapeutics Corp (Medicenna), formerly A2 Acquisition Corp, is a clinical stage immuno-oncology company. The company develops empowered cytokines (EC) and superkines for the treatment of cancer. Its pipeline products include MDNA55, MDNA109, MDNA209, MDNA57, MDNA413, and MDNA132. …
  • Veristat LLC-製薬・医療分野:企業M&A・提携分析
    Summary Veristat LLC (Veristat), a subsidiary of Veristat Holding Inc is a clinical research organization that conducts clinical trials. The organization offers clinical monitoring, clinical project management, data management, CDISC implementation, biostatistics, medical writing, project management …
  • Sectra AB (SECT B):医療機器:M&Aディール及び事業提携情報
    Summary Sectra AB (Sectra) develops and sells technologies for medical systems and secure communication systems. Its operations are concentrated on two major sectors: Image IT Solutions and Secure Communications. The company’s subsidiary, Sectra Imaging IT Solutions AB, offers medical information te …
  • The Coca-Cola Co:企業のM&A・事業提携・投資動向
    The Coca-Cola Co - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's The Coca-Cola Co Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), dives …
  • Pental Limited (PTL):企業の財務・戦略的SWOT分析
    Pental Limited (PTL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Brinker International, Inc.:企業の戦略・SWOT・財務分析
    Brinker International, Inc. - Strategy, SWOT and Corporate Finance Report Summary Brinker International, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Attock Refinery Ltd (ATRL):企業の財務・戦略的SWOT分析
    Summary Attock Refinery Ltd (ARL), a subsidiary of The Attock Oil Co Ltd, is a downstream company that offers refining services. The company refines crude oil and supplies refined petroleum products. Its products include liquefied petroleum gas, petroleum solvent, naphtha, unleaded premium motor gas …
  • Daiho Corporation:企業の戦略・SWOT・財務分析
    Daiho Corporation - Strategy, SWOT and Corporate Finance Report Summary Daiho Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Morphogenesis Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Morphogenesis Inc (Morphogenesis) is a developer of novel cell and gene therapies to detect, monitor and control cancer. The company manufactures products based on distinct and synergistic technology platforms. It uses technologies such as immunefx cancer immunotherapies, the polymer antibod …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆